tobiegroupsoftware

Arizona has no shortage of MedTech ambition. We have smart founders, credible research, and a growing pipeline of startups working on meaningful problems. But even the best ideas can hit a wall early for one simple reason: it is hard to get in front of clinicians in a structured way, early enough, and often enough to shape product development while it still matters. On January 29, 2026, MDM2 took a major step toward solving that challenge by launching its first CME-accredited Clinical...

Sarah Stabenfeldt is trained in biomedical engineering. She earned her undergraduate degree from Saint Louis University with a focus on biomaterials, followed by a PhD in Bioengineering from Georgia Tech, where she specialized in  polymer based material systems for neurotrauma.  She then completed  an NIH funded postdoctoral fellowship jointly administered by Georgia Tech, Emory University, and Morehouse College, This program integrated advanced research with formal pedagogical training and...

In September 2025, the Flinn Foundation released an update  on the organization’s ambitious plan to make Arizona a globally competitive and national leader in areas like precision medicine, neuroscience, bioengineering, cancer, diagnostics and agricultural biotechnology. Originally launched in 2002, Arizona’s Bioscience Roadmap  has already achieved remarkable results in the past two decades-plus. The Medical Device Manufacturing Multiplier (MDM2) consortium’s 2025-2026 Action Plan, also...